Biomimetic Cell Membrane-Engineered Covalent Organic Frameworks for Smart Drug Delivery: Design Principles, Engineering Strategies, and Translational Challenges
Abstract
Covalent organic frameworks (COFs) have attracted growing interest as drug delivery platforms owing to their ordered porosity, tunable pore architecture, and versatile chemical functionality. Favorable physicochemical characteristics alone, however, do not guarantee effective performance in vivo, and biomimetic membrane engineering has emerged as a strategy for modifying the biological interface of COF nanocarriers. This review develops a principle-based framework structured around five interconnected concepts: biological identity transfer, functional mimicry, homotypic targeting, biophysical compatibility, and programmable responsiveness. Rather than treating membrane coating as a universally beneficial modification, it examines how far these functions depend on membrane source, retained biomolecules, membrane orientation, coating quality, and the properties of the underlying framework. Ten primary membrane-engineered COF systems are compared quantitatively across framework chemistry, membrane source and coating method, particle characteristics, cargo loading, release behavior, biological model, pharmacokinetics, therapeutic outcomes, safety, and study limitations. Five membrane-engineering strategies are evaluated against defined fabrication, scalability, integrity, targeting, cost, and regulatory criteria, distinguishing throughout evidence obtained directly in COF systems from findings extrapolated from other nanocarriers. Translational barriers, including donor variability, membrane integrity, immunogenicity, sterility, framework degradation, batch reproducibility, and regulatory requirements, are examined. Current evidence supports preclinical feasibility but not established translational readiness.